Humanising Healthcare podcast - "Achieving Diversity in Medicine Development"

Listen to the podcast on Spotify here Humanising Healthcare - Achieving Diversity in Medicine Development

In this edition:

Manasi is joined by Professor Graham McClelland and PhD Student Fatima Auwal to discuss the diversity achieved in medicine development.

Graham McClelland

Professor of Pharmaceutical Medicine
Graham's LinkedIn Profile

Graham McClelland is a Professor of Pharmaceutical Medicine at the Institute of Pharmaceutical Science, King’s College London, where he is Course Director of the Integrated MSc Apprenticeship in Clinical Pharmacology.
He spent over 30 years working in R&D for the pharmaceutical industry, holding senior international leadership positions in clinical research. He is a qualified biologist, psychologist and pharmacologist.
In 2009 he moved to Egypt, where he formed a public company and carried out teaching and consultancy work. He returned to the UK in 2015 and was appointed as a Non-Executive Director and Deputy Chair of Quantum Care, a leading not-for-profit organisation providing residential care for the elderly.
Professor McClelland has published over 60 book chapters, patents and research articles and has spoken at and chaired conferences across the globe.

Fatima Auwal

PhD Student
Fatima's LinkedIn Profile

I am a Nigerian trained clinical pharmacist interested in improving patient experience with the use of medicines and overall health outcomes. Prior to joining King’s as a PhD student, I was a lecturer at the faculty of pharmaceutical sciences, Ahmadu Bello University, Zaria, Nigeria.
My PhD work at King’s aim to understand how patient engagement can impact drug development and its lifecycle management, this is because of beliefs that-this could lead to better health outcomes for the patients’ and cost-effective development process for the Pharma.

Manasi Nandi

Reader in Integrative Pharmacology

Manasi is a scientist and educator based within the Faculty of Life Sciences and Medicine. Her interdisciplinary research focuses on the extraction of new information from vital signs data, aiding research and clinical decision making, and identifying earlier alerts of disease. She has expertise in medicine discovery and development and the translation of laboratory findings into clinical practice. She is a fellow of the British Pharmacological Society, most recently supporting efforts to embed inclusive principles into the national curriculum. Inclusivity and accessibility are at the core of her teaching and research practice. She is the Development, Diversity and Inclusion lead for the School and Cancer and Pharmaceutical Science, supporting EDI activities at Faculty and College level. She launched the Humanising Healthcare seminar series in 2023.